Atlas Trials

Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

Clinical trial NCT04352309 · COMPLETED

Trial details

NCT number
NCT04352309
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis C Virus (HCV)
Start date
2020-05-29
Primary completion
2021-06-11
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.